Display Settings:

Format

Send to:

Choose Destination
    Nat Rev Cancer. 2006 Feb;6(2):146-55.

    Mapping normal and cancer cell signalling networks: towards single-cell proteomics.

    Source

    Department of Medicine, Oncology Division, Stanford University, Stanford, California 94305, USA.

    Abstract

    Oncogenesis and tumour progression are supported by alterations in cell signalling. Using flow cytometry, it is now possible to track and analyse signalling events in individual cancer cells. Data from this type of analysis can be used to create a network map of signalling in each cell and to link specific signalling profiles with clinical outcomes. This form of 'single-cell proteomics' can identify pathways that are activated in therapy-resistant cells and can provide biomarkers for cancer diagnosis and for determining patient prognosis.

    PMID:
    16491074
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk